Showing results (11-20 of 374) with videos related to
Sort By:
Pageof 38
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 10, 2025
Putative new biomarkers for renal transporter-mediated drug-drug interactions: Characterization as substrates of organic cation transporter 2, multidrug and toxin extrusion protein 1, and other important drug transportersArne Gessner, Jana Picurová, Lea Englhard, et al.Amino Acids|August 8, 2019
Establishment of reference values for the lysine acetylation marker Nɛ-acetyllysine in small volume human plasma samples by a multi-target LC-MS/MS methodArne Gessner, Maren Mieth, Daniel Auge, et al.Antimicrobial Agents and Chemotherapy|April 27, 2011
Molecular mechanism of renal tubular secretion of the antimalarial drug chloroquineFabian Müller, Jörg König, Hartmut Glaeser, et al.Molecular Pharmaceutics|July 15, 2017
Contribution of MATE1 to Renal Secretion of the NMDA Receptor Antagonist MemantineFabian Müller, Dietmar Weitz, Volker Derdau, et al.Amino Acids|July 19, 2013
Transport of asymmetric dimethylarginine (ADMA) by cationic amino acid transporter 2 (CAT2), organic cation transporter 2 (OCT2) and multidrug and toxin extrusion protein 1 (MATE1)Joachim Strobel, Fabian Müller, Oliver Zolk, et al.Clinical Pharmacology and Therapeutics|August 16, 2024
New Biomarkers for Renal Transporter-Mediated Drug-Drug Interactions: Metabolomic Effects of Cimetidine, Probenecid, Verapamil, and Rifampin in HumansArne Gessner, Jörg König, Pia Wenisch, et al.Clinical Pharmacology and Therapeutics|August 4, 2023
A Metabolomic Analysis of Sensitivity and Specificity of 23 Previously Proposed Biomarkers for Renal Transporter-Mediated Drug-Drug InteractionsArne Gessner, Fabian Müller, Pia Wenisch, et al.Plos One|October 2, 2015
Inhibitory Effects of Green Tea and (-)-Epigallocatechin Gallate on Transport by OATP1B1, OATP1B3, OCT1, OCT2, MATE1, MATE2-K and P-GlycoproteinJana Knop, Shingen Misaka, Katrin Singer, et al.Advanced Drug Delivery Reviews|October 31, 2002
The influence of MDR1 polymorphisms on P-glycoprotein expression and function in humansMartin F FrommToxicology|December 31, 2002
Genetically determined differences in P-glycoprotein function: implications for disease riskMartin F FrommPageof 38